Phase 4 Long COVID Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are between 18 and 75 years old
• People whose condition meets the specific disease diagnosis criteria set out for this trial (confirm with trial site)
• People whose condition also meets the traditional Chinese medicine pattern diagnosis criteria set out for this trial (confirm with trial site)
• People who are willing to give their agreement to take part and sign a consent form

Who may not be able to join:

• People who currently need, or are expected to need, advanced breathing support such as high-flow oxygen, breathing machines, or a heart-lung bypass machine (ECMO)
• People with a known history of active liver disease — such as active hepatitis B or C, a specific type of liver scarring (primary biliary cirrhosis), moderate or severe liver failure, or sudden liver failure — or whose blood test results at the start of the trial show certain liver markers above acceptable levels
• People who are on dialysis, or who have been found in the past 6 months to have moderate to severe kidney disease based on a specific kidney function calculation
• People who, in the 6 months before the trial, have had moderate to severe heart failure, a stroke, a heart attack, or a coronary artery stent placed; or who have uncontrolled high blood pressure or certain significant heart rhythm abnormalities on an ECG
• People who had influenza A, influenza B, or another infectious illness in the 3 months before the trial
• People who have, or have ever had, a serious neurological condition such as epilepsy or seizures, a mental illness, or a family history of mental illness
• People who are pregnant or breastfeeding, or who have a positive pregnancy test before starting the study medication
• People who have had a malignant (cancerous) tumour in the 5 years before the trial, or whose cancer is currently active or progressing and may need treatment during the study
• People who have chronic fatigue syndrome or an autoimmune disease such as rheumatoid arthritis or lupus
• People who have a known allergy to any ingredient in the study drug
• People whose overall health condition is considered by the trial doctor to make participation unsuitable
• People who have taken certain traditional Chinese medicines containing specific herbs — Codonopsis pilosula, Ophiopogon japonicus, Schisandra chinensis, or Astragalus membranaceus — in the 2 weeks before the trial
• People who are currently taking part in another clinical trial involving a drug or medical device

Important: Always verify eligibility with the trial site directly before applying.